Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
Shufen Li, Meidi Ye, Yuanqiao Chen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12

Showing 12 citing articles:

Toosendanin induced hepatotoxicity via triggering PERK-eIF2α-ATF4 mediated ferroptosis
Yonghong Liang, Sixin Chen, Suqin Han, et al.
Toxicology Letters (2023) Vol. 377, pp. 51-61
Closed Access | Times Cited: 16
Rift Valley Fever Virus Nucleoprotein Triggers Autophagy to Dampen Antiviral Innate Immune Responses
Xiangtao Zhu, Zihan Guan, Yujie Fang, et al.
Journal of Virology (2023) Vol. 97, Iss. 4
Open Access | Times Cited: 10
Plant‐derived compounds as potential leads for new drug development targeting COVID‐19
Lingxiu Liu, Maxim V. Kapralov, Mark Ashton
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1522-1554
Open Access | Times Cited: 3
Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1
Bin Liu, Xiaoqian Jiao, Xufeng Dong, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 231-231
Open Access | Times Cited: 3
Recent Advances in the Study of the Immune Escape Mechanism of SFTSV and Its Therapeutic Agents
Lei Chen, Tingting Chen, Ruidong Li, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 940-940
Open Access | Times Cited: 9
Therapeutic potential of toosendanin: Novel applications of an old ascaris repellent as a drug candidate
Minghao Hu, Min Xu, Yuchen Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115541-115541
Open Access | Times Cited: 8
Toosendanin suppresses African swine fever virus replication through upregulating interferon regulatory factor 1 in porcine alveolar macrophage cultures
Yuanjia Liu, Xinheng Zhang, Zexin Liu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 11
FROM NATURE'S PHARMACY TO SWINE HEALTH: HARNESSING NATURAL COMPOUNDS AGAINST PRRSV INFECTION
Fredmoore L. Orosco
Slovenian Veterinary Research (2024)
Open Access | Times Cited: 2
Toosendanin activates caspase-1 and induces maturation of IL-1β to inhibit type 2 porcine reproductive and respiratory syndrome virus replication via an IFI16-dependent pathway
Mingxin Zhang, Chunni Lu, Lizhan Su, et al.
Veterinary Research (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 8
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus
Cigdem Alkan, Terrence P. O’Brien, Victor Kenyon, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 88-88
Open Access | Times Cited: 1
Toosendanin induces hepatotoxicity via disrupting LXRα/Lipin1/SREBP1 mediated lipid metabolism
Sixin Chen, Jiajie Ni, Li Luo, et al.
Food and Chemical Toxicology (2024) Vol. 187, pp. 114631-114631
Closed Access | Times Cited: 1
Antiviral Activity and Molecular Dynamics Simulation of Hops Compounds against Oropouche Virus (Peribunyaviridae)
Tsvetelina Mandova, Marielena Vogel Saivish, Gabriela de Lima Menezes, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2769-2769
Open Access | Times Cited: 3
Page 1

Scroll to top